CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Accounting Officer gave up 602 shares (to pay taxes)
- 4 Grant or award Interim PEO acquired 3,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 600 shares (to pay taxes)
- 4 Grant or award Director acquired 16,399 shares (grant or award)
- 4 Grant or award Director acquired 16,399 shares (grant or award)
- 4 Grant or award Director acquired 16,399 shares (grant or award)
- 4 Grant or award Director acquired 16,399 shares (grant or award)
- 4 Grant or award Director acquired 16,399 shares (grant or award)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 601 shares (to pay taxes)
- 4 Grant or award Chief Accounting Officer acquired 8,154 shares (grant or award)
- 4 Grant or award Interim PEO acquired 14,677 shares (grant or award)
- 4 Open-market buy Director bought 15,000 shares at $15.90 ($238,500)
- 4 Open-market sale Chief Accounting Officer sold 5,617 shares at $16.00 ($89,872)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,353 shares (to pay taxes)
- 4 Open-market buy Director bought 10,000 shares at $14.90 ($148,958)
- 4/A Shares withheld for taxes Interim PEO gave up 3,093 shares (to pay taxes)
- 4 Open-market buy Interim PEO bought 7,000 shares at $14.80 ($103,600)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 540 shares (to pay taxes)
- 4 Grant or award Chief Accounting Officer acquired 1,779 shares (grant or award)
Page 8 of 39 · 776 filings